Introduction
The Human CD142/F3/TF HEK293T Stable Cell Line is a valuable tool in the field of immunology and cancer research. This cell line is stably transfected with the gene encoding for CD142, also known as tissue factor (TF) or coagulation factor III, which is a transmembrane protein involved in blood coagulation and inflammatory processes. This article will provide a detailed description of the structure, activity, and application of this cell line, highlighting its importance as a therapeutic target and its utility in flow cytometry.
Structure of Human CD142/F3/TF HEK293T Stable Cell Line
The Human CD142/F3/TF HEK293T Stable Cell Line is derived from the human embryonic kidney cell line HEK293T, which is widely used in biological research due to its high transfection efficiency and robust growth characteristics. The stable transfection of the CD142 gene into HEK293T cells results in the expression of the full-length CD142 protein, which consists of 263 amino acids and has a molecular weight of approximately 47 kDa.
CD142 is a type I transmembrane protein that contains a large extracellular domain, a transmembrane domain, and a short cytoplasmic tail. The extracellular domain of CD142 is responsible for binding to its ligand, coagulation factor VII, and initiating the coagulation cascade. The transmembrane domain anchors CD142 to the cell membrane, while the cytoplasmic tail contains signaling motifs that regulate the activity of CD142.
Activity of Human CD142/F3/TF HEK293T Stable Cell Line
The primary function of CD142 is to initiate the extrinsic pathway of blood coagulation. Upon binding to coagulation factor VII, CD142 forms a complex that activates coagulation factor X, leading to the formation of a blood clot. In addition to its role in blood coagulation, CD142 has been shown to play a crucial role in inflammatory processes. It can induce the expression of pro-inflammatory cytokines and adhesion molecules, promoting the recruitment of immune cells to the site of inflammation.
The stable expression of CD142 in the HEK293T cell line allows for the study of its activity in a controlled and reproducible setting. This cell line can be used to investigate the signaling pathways involved in CD142-mediated coagulation and inflammation. It can also be used to screen for potential inhibitors of CD142 activity, which could have therapeutic potential in diseases associated with abnormal blood coagulation and inflammation.
Application of Human CD142/F3/TF HEK293T Stable Cell Line
The Human CD142/F3/TF HEK293T Stable Cell Line has a wide range of applications in both basic and translational research. Its stable expression of CD142 makes it an ideal model for studying the role of CD142 in various disease states, including cancer, autoimmune disorders, and cardiovascular diseases.
One of the most significant applications of this cell line is in flow cytometry. The stable expression of CD142 allows for the detection and quantification of this protein on the surface of cells using specific antibodies. This technique can be used to study the expression of CD142 in different cell types and under various conditions, providing valuable insights into its role in disease processes.
Moreover, the Human CD142/F3/TF HEK293T Stable Cell Line can be used as a therapeutic target for the development of novel anti-coagulant and anti-inflammatory drugs. The stable expression of CD142 in this cell line allows for the screening of potential inhibitors and their efficacy in blocking CD142-mediated signaling.
Conclusion
In summary, the Human CD142/F3/TF HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of CD142 in various disease states. Its stable expression of CD142 allows for the investigation of its role in blood coagulation and inflammation, and its utility in flow cytometry makes it an essential tool in immunology and cancer research.
There are no reviews yet.